X0306 4 2013-06-28 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001532219 Quinn Anthony 33 HAYDEN AVE LEXINGTON MA 02421 false true false false SVP, Chief Medical Officer Common Stock 2013-06-28 5 A false 297 35.68 A 15332 D The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Synageva BioPharma Corp. Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2013 through June 30, 2013. This transaction is also exempt under Rule 16b-3(c). The Option Period (as defined in the ESPP) ended on June 30, 2013, so the shares were acquired on June 28, 2013, the last trading day prior to the end of the Option Period. In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2013. /s/ Anthony Quinn 2013-07-01